Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) EVP Roberton James Stevenson sold 142 shares of the stock in a transaction on Thursday, June 16th. The stock was sold at an average price of $76.56, for a total value of $10,871.52. Following the completion of the sale, the executive vice president now directly owns 5,896 shares in the company, valued at $451,397.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Roberton James Stevenson also recently made the following trade(s):
- On Thursday, March 31st, Roberton James Stevenson sold 72 shares of Addus HomeCare stock. The stock was sold at an average price of $90.77, for a total value of $6,535.44.
ADUS stock traded up $0.98 during trading on Friday, reaching $77.81. The stock had a trading volume of 74,554 shares, compared to its average volume of 78,524. Addus HomeCare Co. has a 52 week low of $68.57 and a 52 week high of $108.11. The stock’s 50 day moving average is $83.90 and its two-hundred day moving average is $83.61. The company has a current ratio of 2.65, a quick ratio of 2.65 and a debt-to-equity ratio of 0.44. The firm has a market cap of $1.25 billion, a PE ratio of 27.64, a PEG ratio of 2.13 and a beta of 0.87.
A number of hedge funds have recently bought and sold shares of the business. Bank of America Corp DE raised its stake in shares of Addus HomeCare by 7.0% in the first quarter. Bank of America Corp DE now owns 111,782 shares of the company’s stock worth $10,428,000 after buying an additional 7,332 shares during the period. Van Hulzen Asset Management LLC raised its stake in shares of Addus HomeCare by 15.6% in the first quarter. Van Hulzen Asset Management LLC now owns 8,518 shares of the company’s stock worth $795,000 after buying an additional 1,147 shares during the period. Avalon Investment & Advisory bought a new position in shares of Addus HomeCare in the first quarter worth about $3,782,000. Quantbot Technologies LP raised its stake in shares of Addus HomeCare by 1,014.9% in the first quarter. Quantbot Technologies LP now owns 1,349 shares of the company’s stock worth $125,000 after buying an additional 1,228 shares during the period. Finally, Eaton Vance Management raised its stake in shares of Addus HomeCare by 20.9% in the first quarter. Eaton Vance Management now owns 754,080 shares of the company’s stock worth $70,348,000 after buying an additional 130,469 shares during the period. 96.04% of the stock is currently owned by institutional investors.
ADUS has been the topic of a number of recent research reports. Royal Bank of Canada cut their target price on Addus HomeCare from $125.00 to $111.00 in a research note on Wednesday, May 4th. Bank of America initiated coverage on Addus HomeCare in a report on Wednesday, April 13th. They set a “buy” rating and a $110.00 price target on the stock. Finally, StockNews.com initiated coverage on Addus HomeCare in a report on Thursday, March 31st. They set a “buy” rating on the stock. Four analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Addus HomeCare has a consensus rating of “Buy” and an average target price of $112.00.
About Addus HomeCare (Get Rating)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
- Get a free copy of the StockNews.com research report on Addus HomeCare (ADUS)
- MarketBeat: Week in Review 6/13 – 6/17
- eBay’s Long Term Fundamentals Are Intact If You Can Stomach Short Term Volatility
- Honda’s Stock Continues To Fly Under The Radar
- Vuzix Stock Stays Optimistic
- Palo Alto Networks: Pioneering AI in Cybersecurity
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.